[https://go.communications.gatesfoundation.org/l/701613/2020-02-27/bmlw5/7016...] Dear Colleague, Below are links to read about a new grant opportunity under the Michelson Prizes and a still-open grant opportunity under a new initiative launched by partners: the Novo Nordisk Foundation, Open Philanthropy, and the Bill & Melinda Gates Foundation. Grant Opportunities The Michelson Prizes are accepting applications<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2F2022-04-15%2Fl7qxl%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=%2BRXHq4UV8IW50puo%2Bbj%2BJ5E%2Flnph0xRPOUUMr7UUdKQ%3D&reserved=0> from young investigators for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. The application deadline is June 26, 2022. The Novo Nordisk Foundation, Open Philanthropy, and the Bill & Melinda Gates Foundation have launched<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2Fnd-preventing-future-pandemics%2Fl7qxp%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=wGzW6yTIwTnLB2i%2BSd9e3Tr8II7YnzSao7VqSV9am3A%3D&reserved=0> the Pandemic Antiviral Discovery (PAD) initiative to catalyze discovery and early development of antiviral medicines for future pandemics. This initiative's first request for proposals (RFP)<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2Fus-request-for-proposals-2022-%2Fl7qxs%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=DFOopq%2B9pQSOAsILQztuUJvmGiQzWUjTZNIARtvXI8I%3D&reserved=0> will focus on henipavirus, a subfamily of paramyxovirus that includes Nipah virus—a pathogen with an estimated fatality rate of 40% to 75%. Researchers from around the world are encouraged to submit proposals; the application deadline is May 5, 2022. Future RFPs will be announced on the initiative's website<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2F2022-04-15%2Fl7qxw%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=iXpXvy5HMRlAXNnK9Wsr2QwBWMS3QyhMf9GTCVjawPc%3D&reserved=0>. Perspective on COVID-19 The Bill & Melinda Gates Foundation continues to work with the public and private sectors in the global response to COVID-19. To learn more about the foundation's broader work and how COVID-19 is being addressed across the foundation, please visit the foundation's website<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2F2022-04-15%2Fl7qxz%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=q2nb4RaTXDDBh%2B6u485m6HKtgqsKfs%2BzbJhWG0tPrqk%3D&reserved=0> and media center<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2Fideas-media-center%2Fl7qy3%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=KOpbMn4ZIVXd1GjSTfP%2BKffpOkyKK6XYJ3oaGyEFonU%3D&reserved=0>, sign-up<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2FIdeas%2Fl7qy6%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=vaBUA8ntNOD%2BmQXIjiSgy3efzHJwSRhKlskyJqQWhZI%3D&reserved=0> for The Optimist newsletter, and browse videos from the 2021 Grand Challenges Annual Meeting<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2Foston28Virtual29-search--list-%2Fl7qy9%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=9mUpLtrww3j1F25tGjoQD2z%2Fj5vLkthXU2pHiT%2Fzt6Y%3D&reserved=0>. Grand Challenges Partnership Network We invite you to read summaries of the grants<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2F3H6dF2k%2Fl7qyd%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=W9UwpI%2F%2BrawiKUmomlooeBk8Unp8QOjnJmep0kQl1bY%3D&reserved=0> awarded to date through Grand Challenges initiatives with the Gates Foundation as funder or co-funder and to explore an interactive world map<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2F--map%2Fl7qyh%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=Ik%2B9sH2lWrOMz%2Bf7B3pIpp6DO9SoHzGf0h1JjcBEYA0%3D&reserved=0> of projects across the broader Grand Challenges funding partner network. This map is filling in over time<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2F-autoplay-true%2Fl7qyl%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=ont9U9tFiRgsz0NJSTEKw17m2sRtB2KTKfyEuOJQlzM%3D&reserved=0>, increasingly with locally led programs in the countries most affected by global health inequities. And if you were forwarded this message, please sign up<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Fe%2F701613%2Fnewsletter%2Fl7qyp%2F673634495%3Fh%3D9S_73-8XGjzdZ0w1iZCvKeXg2Am4mj-xeZiS8IEdjmQ&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=RKaTRtUc0giBO0g1DtSBIG33hzCDhfUF%2ByEfyY%2FhXUo%3D&reserved=0> on our Grand Challenges website for email updates with the latest opportunities to apply for a grant. Wishing you and those close to you all the best, The Global Partnerships & Grand Challenges team __________________________________ Visit our Grand Challenges website gcgh.grandchallenges.org<https://nam11.safelinks.protection.outlook.com/?url=http%3A%2F%2Fgcgh.grandchallenges.org%2F&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=JwrYhN8A%2F28DpdAU3MQGJCryIv7bxFORqfc3vO4Z%2F8c%3D&reserved=0> Privacy Policy www.gatesfoundation.org/privacy-and-cookies-notice<https://nam11.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.gatesfoundation.org%2FPrivacy-and-Cookies-Notice&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=LuTNrFG5l52C8%2BDF%2FgF4zNz012mS6gtMBESP17dmTII%3D&reserved=0> Unsubscribe You are currently subscribed as: llhenzl@prf.org<mailto:llhenzl@prf.org> Click to Manage List Preferences<https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgo.communications.gatesfoundation.org%2Femail-preferences%3Fehash%3D078fe8a1091928d4b7e55a86cd4e63ea8134c668c572c64cd4ac48eb76579f4f%26email_id%3D673634495%26epc_hash%3DPFSeXJr3Wn3Qd-JEMFQ4ZffuLZmSw_ImlGduozqPW4E&data=05%7C01%7C%7Cc78d980065414393d63f08da1eef3425%7Ce25b40edf9c844b99420fe1c86641854%7C0%7C0%7C637856310178997547%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=9YFi6Ji2tePotZ8OvqikfUVX1WilbzQ8e7tASOc4%2BGY%3D&reserved=0> PO Box 23350 Seattle, WA. 98102 (C) 1999-2022 Bill & Melinda Gates foundation. All Rights Reserved.